bioAffinity Techn…
USUSDbioAffinity Technologies, Inc. (US:BIAF) — Biotechnology: Commercial Physical & Biological Resarch. Broj burzi na kojima se trguje dionicama tvrtke: 1. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.
O Tvrtki
- Web-Stranica
- bioaffinitytech.com
- Odnosi s Investitorima
- bioaffinitytech.com/contact/
- Sektor
- Health Care · Biotechnology: Commercial Physical & Biological Resarch
- Sjedište
- SAN ANTONIO, United States
- Glavni Direktor
- Maria Zannes
- Zaposlenici
- 57
- Dionice u Optjecaju
- 8.1 mil. na dan 2026-08-03
- Slobodno Prenosive Dionice
- 532 257
- Tržišna Kapitalizacija
- 3.69 mil. USD
- Insajderi
- 0.82%
- Institucionalni Ulagači
- 5.62%
- Djelatnost (SIC)
- Services-Commercial Physical & Biological Research
- P/E
- gubitak
- FCF
- −11.6 mil. USD
- Dug
- 36.5 tis. USDneto novac
- Zarada i FCF — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
- NAV
Opis
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Burze i Oznake
| Burza | Oznaka | Valuta | Cijena | Vrsta |
|---|---|---|---|---|
| US USA Stocks | BIAF | USD | 3.51 -5.90% | obične dionice |
Vijesti Ovog Tjedna
Priopćenja za medije s web stranice za investitore tvrtke, ažurirana svakodnevno. Poveznice vode na web stranicu tvrtke. Naslovi su na izvornom jeziku, kao na web stranici tvrtke.
Najveći Imatelji
| Imatelj | Udio | Dionice | Datum Izvješća |
|---|---|---|---|
| ZANNES MARIA (Chief Exec… | ≈46.94% | 280 359 | 2025-01-10 |
| EDWARDS JAMES MICHAEL CP… | ≈20.11% | 120 128 | 2025-01-10 |
| ZANNES TIMOTHY PETER (Ge… | ≈9.17% | 54 765 | 2025-01-10 |
| REVELES XAVIER TRINIDAD… | ≈7.02% | 41 943 | 2025-01-10 |
| Sabby Management, LLC | 4.06% | 24 377 | 2026-06-30 |
| Blackrock Inc. | 1.1% | 6 585 | 2026-06-30 |
| Vanguard Capital Managem… | 0.62% | 3 703 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.62% | 3 703 | 2026-06-30 |
| Geode Capital Management… | 0.57% | 3 398 | 2026-06-30 |
| J. Safra Sarasin Holding… | 0.47% | 2 840 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.34% | 2 071 | 2026-06-30 |
| Susquehanna Internationa… | 0.3% | 1 791 | 2026-06-30 |
| Jane Street Group, LLC | 0.3% | 1 786 | 2026-06-30 |
| Fidelity Concord Street… | 0.28% | 1 659 | 2026-07-31 |
| State Street Corporation | 0.27% | 1 606 | 2026-06-30 |
| HRT Financial LP | 0.23% | 1 389 | 2026-06-30 |
| Fidelity Concord Street… | 0.08% | 509 | 2026-07-31 |
| Fidelity Concord Street… | 0.07% | 434 | 2026-07-31 |
| Fidelity Concord Street… | 0.03% | 167 | 2026-07-31 |
| GIRGENTI STEVEN (Officer… | — | 1.09 mil. | 2025-01-10 |
